Is decrease of tumor volume correlated with stage change after preoperative concurrent chemoradiotherapy?

Hepato-Gastroenterology

Volumn 52, Issue 63, 2005, Pages 765-769

  Yang, Shung Haur ^a,b   Lee, Rheun Chuan ^a   Chen, Chien Chih ^a   Jiang, Jeng Kae ^a   Lin, Jen Kou ^a   Li, Anna Fen Yau ^a   Liang, Wen Yih ^a   Wang, Ling Wei ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cancer; Chemoradiation; MRI; Rectum; Tumor volume

Indexed keywords

FLUOROURACIL; FOLINIC ACID; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; PRODRUG; URACIL;

ADULT; AGE; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE REGIMEN; EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LINEAR ACCELERATOR; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; RECTUM CARCINOMA; RECTUM RESECTION; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PRODRUGS; RECTAL NEOPLASMS; RECTUM; TREATMENT OUTCOME; URACIL;

EID: 20644446289     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Douglass HO, Jr., Moertel CG, Mayer RJ, Thomas PR, Lindblad AS, Mittleman A, et al: Survival after postoperative combination treatment of rectal cancer. New Engl J Med 1986; 315:1294-1295.
2. Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, et al: Effective surgical adjuvant therapy for high-risk rectal carcinoma. New Engl J Med 1991; 324:709-715.
3. Minsky BD: Preoperative combined modality treatment for rectal cancer. Oncol (Huntington) 1994; 8:53-58, 61; discussion 61, 64-68.
4. Bosset JF, Pavy JJ, Pelissier E, Gillet M, Mantion G, Arbez-Gindre F, et al: [External adjuvant radiation therapy in rectal cancers. Analysis and results of randomized trials]. Gastroen Clin Biol 1991; 15:540-547.
5. Wong CS, Cummings BJ, Keane TJ, Dobrowsky W, O'Sullivan B, Catton CN: Combined radiation therapy, mitomycin C, and 5-fluorouracil for locally recurrent rectal carcinoma: results of a pilot study. Int J Radiat Oncol, Biol, Phy 1991; 21:1291-1296.
6. Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Reichman B, et al: Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J Clin Oncol 1992; 10:79-84.
7. Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Saltz L, et al: The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. Cancer 1993; 71:3486-3492.
8. Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Reichman B, et al: Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. J Clin Oncol 1992; 10:1218-1224.
9. Janjan NA, Abbruzzese J, Pazdur R, Khoo VS, Cleary K, Dubrow R, et al: Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiotherapy Oncol 1999; 51:153-160.
10. Rauch P, Bey P, Peiffert D, Conroy T, Bresler L: Factors affecting local control and survival after treatment of carcinoma of the rectum by endocavitary radiation: a retrospective study of 97 cases. Int J Rad Oncol Biol Physi 2001; 49:117-124.
11. Ruo L, Tickoo S, Klimstra DS, Minsky BD, Saltz L, Mazumdar M, et al: Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg 2002; 236:75-81.
12. Theodoropoulos G, Wise WE, Padmanabhan A, Kerner BA, Taylor CW, Aguilar PS, et al: T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 2002; 45:895-903.
13. Indinnimeo M, Grasso RF, Cicchini C, Pavone P, Stazi A, Catalano C, et al: Endorectal magnetic resonance imaging in the preoperative staging of rectal tumors. Int Surg 1996; 81:419-422.
14. Hoff PM, Saad ED, Janjan N, Skibber J, Pazdur R: A phase I study. Preoperative UFT/leucovorin and radiation therapy in rectal cancer. Oncol (Huntington) 2000; 14:56-58.
15. Sarashina H, Taniyama S, Saitoh N, Nunomura M, Nakayama H, Okui K: [Preoperative radiotherapy in rectal carcinoma. I. The effect of irradiation on the tumor volume]. Strahlentherapie und Onkologie 1990; 166:794-797.
16. Garcia-Aguilar J, Hernandez de Anda E, Sirivongs P, Lee SH, Madoff RD, Rothenberger DA: A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 2003; 46:298-304.
17. Janjan NA, Crane CN, Feig BW, Cleary K, Dubrow R, Curley SA, et al: Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. Int J Rad Oncol Biol, Physi 2000; 47:713-718.